UCB's new CEO appoints executive team
This article was originally published in Scrip
UCB's new chief executive Jean-Christophe Tellier, who took up the post 1 January 2015, has revealed new appointments at the company, and has confirmed the company's leadership team. Mr Tellier, who succeeds Roch Doliveux as CEO, has been with UCB since 2011.
You may also be interested in...
A complete response letter from the FDA in June knocked Intercept’s stock price down to 2014 levels, but perhaps the regulator is sending wider messages about NASH.
A selection of features you might have missed from the first six months of 2020, covering key topics from COVID-19 strategies in medtech to an analysis of pipeline focus areas across the pharma sector. Click on each section to get the full story behind the data.
The two-part vaccine becomes the second against Ebola to get approval. Janssen is now collaborating with the World Health Organization on vaccine pre-qualification to get it to people in need.